Certolizumab pegol

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Certolizumab pegol and local guidelines before prescribing.

Biologic (anti-TNF)

Mechanism

PEGylated anti-TNF Fab fragment.

Uses

Rheumatoid arthritis, Crohn disease, psoriasis, axial spondyloarthritis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infections, injection-site reactions, TB reactivation.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active infection, moderate to severe heart failure

Monitoring

TB screen, infection

Pregnancy and breastfeeding

Used in pregnancy where needed

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Minimal placental transfer, so used in pregnancy when needed.

More from the textbook: uses, cautions and other points
Where it is discussed in the book